Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.